SSRIs n (%) | TCA n (%) | MAOIs n (%) | Others n (%) | |
---|---|---|---|---|
Total | 55,236 (52.3a) | 13,708 (13.0a) | 255 (0.2a) | 53,971 (51.1a) |
Gender | ||||
Female | 37,864 (68.5) | 9411 (68.7) | 145 (43.1) | 35,222 (65.3) |
Male | 17,372 (31.5) | 4297 (31.3) | 110 (56.9) | 18,749 (34.7) |
Age group | ||||
0–14 | 103 (0.2) | 5 (0.1) | 0 (0.0) | 78 (0.1) |
15–24 | 2284 (4.1) | 309 (2.3) | 5 (2.0) | 1875 (3.5) |
25–34 | 4469 (8.1) | 738 (5.4) | 20 (7.8) | 4033 (7.5) |
35–44 | 7205 (13.0) | 1358 (9.9) | 41 (16.1) | 6701 (12.4) |
45–54 | 9751 (17.7) | 2371 (17.3) | 51 (20.0) | 10,026 (18.6) |
55–64 | 9357 (16.9) | 2842 (20.7) | 43 (16.9) | 9043 (17.9) |
65–74 | 8216 (14.9) | 2672 (19.5) | 52 (20.4) | 7958 (14.7) |
75–84 | 8044 (14.6) | 2264 (16.5) | 25 (9.8) | 8125 (15.1) |
≥ 85 | 5807 (10.5) | 1149 (8.4) | 18 (7.1) | 5522 (10.2) |
Area of residence | ||||
Urban area | 44,086 (79.8) | 10,776 (78.6) | 205 (80.4) | 42,790 (79.3) |
Rural area | 11,150 (20.2) | 2932 (21.4) | 50 (19.6) | 11,181 (20.7) |